4/A: Director William Milmoe Reports INBP Share Transfers
Statement of Changes in Beneficial Ownership
Director William H. Milmoe filed an amended Form 4 to correct the transaction date for the transfer of Integrated Biopharma, Inc. shares to CDDS 2.0, LLC.
Summary
- Director William H. Milmoe reported the transfer of 8,966,547 shares of Common Stock from CD Financial, LLC to CDDS 2.0, LLC.
- An additional 2,235,417 shares were transferred from the Carl DeSantis Revocable Trust to CDDS 2.0, LLC.
- The filing serves as an amendment to correct the 'Date of Earliest Transaction' from 03/24/2026 to 04/15/2026.
- CDDS 2.0, LLC is controlled by Damon DeSantis.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral administrative update regarding share ownership transfers between related entities.
Positives
- The filing provides transparency regarding significant changes in the beneficial ownership structure of the company.
Negatives
- The initial filing contained an administrative error regarding the transaction date, necessitating an amendment.
Risks
- Concentration of ownership within entities controlled by Damon DeSantis may influence future corporate governance decisions.
Future Outlook
No forward-looking guidance or operational outlook was provided in this ownership disclosure.
Industry Context
StockSavvy.ai notes that this filing reflects internal restructuring of shareholdings among major stakeholders rather than a change in the company's operational or financial trajectory.
Comparison to Industry Standards
- The filing follows standard SEC disclosure requirements for Section 16 reporting persons.
- Administrative amendments for date corrections are common in corporate filings and do not deviate from standard regulatory compliance practices.
Related Party Transactions
- Transfer of shares between CD Financial, LLC, the Carl DeSantis Revocable Trust, and CDDS 2.0, LLC, all of which are related to the DeSantis family interests.
Stakeholder Impact
- Shareholders should note the consolidation of voting power within CDDS 2.0, LLC.
Next Steps
- Continued monitoring of SEC filings for further changes in beneficial ownership or control.
Key Dates
| Date | Description |
|---|---|
| 04/15/2026 | Actual date of the share transfer transactions. |
| 04/17/2026 | Date of the amended SEC filing. |
Keywords
Integrated Biopharma, INBP, Form 4, Insider Trading, Beneficial Ownership, William Milmoe, Damon DeSantis
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.